Pancreatic Cancer Research

ResearcherTongji UniversityNo recent work listed

Bo Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0812-5775; OpenAlex author ID A5100427402. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper

Papers 2

  1. The small-molecule IAP antagonist AT406 inhibits pancreatic cancer cells in vitro and in vivo. Co-author DOI 10.1016/j.bbrc.2016.07.011↗
  2. Cisplatin-induced non-apoptotic death of pancreatic cancer cells requires mitochondrial cyclophilin-D-p53 signaling. Co-author DOI 10.1016/j.bbrc.2013.06.103↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Baoyou Sun · 1 shared paper, 2016 · strength 0.07
  2. Yongsheng Jiang · 1 shared paper, 2016 · strength 0.07
  3. Lei Gong · 1 shared paper, 2013 · strength 0.04
  4. Tu Dai · 1 shared paper, 2013 · strength 0.04
  5. Gaojue Wu · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.